Business Description
Eurocine Vaccines AB
NAICS : 325412
SIC : 2834
ISIN : SE0015382155
Compare
Compare
Traded in other countries / regions
EUCI.Sweden8X4.Germany IPO Date
2006-12-12Description
Eurocine Vaccines AB focuses on the development and sale of nasal vaccines in Sweden. The company is developing nasal influenza vaccines, nasal vaccines for bird flu, nasal vaccines for pneumococcal disease such as pneumonia and meningitis. It offers vaccines for both children and adults.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | -0.13 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 29.8 | |||||
| 3-Year EPS without NRI Growth Rate | 29.3 | |||||
| 3-Year FCF Growth Rate | 28.9 | |||||
| 3-Year Book Growth Rate | -66.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 49.49 | |||||
| 9-Day RSI | 50.86 | |||||
| 14-Day RSI | 51.89 | |||||
| 6-1 Month Momentum % | 8.67 | |||||
| 12-1 Month Momentum % | -81.73 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.88 | |||||
| Quick Ratio | 0.88 | |||||
| Cash Ratio | 0.66 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -41.7 | |||||
| Shareholder Yield % | -71.89 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -297.2 | |||||
| ROA % | -205.17 | |||||
| ROIC % | -653.55 | |||||
| ROC (Joel Greenblatt) % | -788.18 | |||||
| ROCE % | -297.51 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.51 | |||||
| EV-to-EBITDA | -0.51 | |||||
| EV-to-FCF | -0.64 | |||||
| Earnings Yield (Greenblatt) % | -196.32 | |||||
| FCF Yield % | -141.46 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Eurocine Vaccines AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | |||
| EPS (TTM) (kr) | -0.188 | ||
| Beta | -0.84 | ||
| Volatility % | 430.29 | ||
| 14-Day RSI | 51.89 | ||
| 14-Day ATR (kr) | 0.015149 | ||
| 20-Day SMA (kr) | 0.04738 | ||
| 12-1 Month Momentum % | -81.73 | ||
| 52-Week Range (kr) | 0.0146 - 0.868055 | ||
| Shares Outstanding (Mil) | 191.91 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Eurocine Vaccines AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Eurocine Vaccines AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Eurocine Vaccines AB Frequently Asked Questions
What is Eurocine Vaccines AB(XSAT:EUCI)'s stock price today?
The current price of XSAT:EUCI is kr0.05. The 52 week high of XSAT:EUCI is kr0.87 and 52 week low is kr0.01.
When is next earnings date of Eurocine Vaccines AB(XSAT:EUCI)?
The next earnings date of Eurocine Vaccines AB(XSAT:EUCI) is 2024-05-30.
Does Eurocine Vaccines AB(XSAT:EUCI) pay dividends? If so, how much?
Eurocine Vaccines AB(XSAT:EUCI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers